Skip to main content
SpringerLink
Log in

Varenicline

  • Farmacotherapie
  • Published:
Tijdschrift voor praktijkondersteuning Aims and scope

Samenvatting

Roken is geassocieerd met een verhoogd risico op onder meer cardiovasculaire en maligne aandoeningen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatuur

  1. Productinformatie metformine, via: www.cbg-meb.nl, Geneesmiddeleninformatiebank.

  2. Informatorium Medicamentorum. Den Haag: KNMP, 2015.

  3. Productinformatie varenicline (Champix®), via: www.ema.europa.eu, human medicines, EPAR’s.

  4. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013:CD009329.

  5. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012:CD006103.

  6. www.fda.gov/cder/drug/infopage/varenicline/default.htm.

  7. US pilots told not to use Chantix. Scrip world pharmaceutical news 2008;66(3365):20.

  8. Chavannes NH, Kaper J, Frijling BD, Van der Laan JR, Jansen PWM, Guerrouj S. NHG-Standaard Stoppen met roken. www.nhg.org.

  9. Anoniem. Varenicline en onttrekkingsverschijnselen. Gebu 2013;47:22.

  10. Bijl D. Varenicline: risico op bepaalde cardiovasculaire bijwerkingen. Gebu 2011;45:118–9.

    Google Scholar 

  11. Prescrire Editorial Staff. “Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects!” Prescrire International 2014;23:208.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Geneesmiddelenbulletin, Mercatorlaan 1200, 3528, Utrecht, BL, The Netherlands

    Dick Bijl

Authors
  1. Dick Bijl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dick Bijl.

Additional information

Auteursgegevens

Geneesmiddelenbulletin, Mercatorlaan 1200, 3528 BL Utrecht: dr. D. Bijl, arts-epidemioloog/hoofdredacteur. Correspondentie: d.bijl@geneesmiddelenbulletin.nl. Mogelijke belangenverstrengeling: niets aangegeven.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bijl, D. Varenicline. TIJD. PRAKT.ONDERST. 10, 61–63 (2015). https://doi.org/10.1007/s12503-015-0032-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12503-015-0032-9

Search

Navigation